Search
Exact matches only
Search in title
Search in content
Search in comments
Search in excerpt
Search in posts
Search in pages
Search in groups
Search in users
Search in forums
Filter by Custom Post Type
Filter by Categories
Filter by Report Categories
Advance Interior Materials
Agriculture Industry
Agrochemicals & fertilizers
Animal feed and feed additives
Automotive Sector
Automotive & Transportation
Biotechnology
Building & Construction
Building & Construction Materials
Electronics & Semiconductors
Electronic Devices
Electronic Security
Energy & Resources
Alternative Energy
Distribution & Utilities
Power generation and storage
Food & Beverage
Food Additives and Nutricosmetics
Life Sciences
Healthcare
Wellness
Personal Care & Cosmetics
Materials & Chemicals
Advanced Materials
Advanced Materials (Green Building Materials)
Ceramic & Fiber
Coatings & printing inks
Organic Chemicals
Paints
Petrochemicals
Plastics
Polymers & Resins
Renewable Chemicals
Specialty & Fine Chemicals
Specialty glass
Specialty Polymer
Medical Devices
Pharmaceuticals
Clinic Diagnostics
Technology & Media
Communication Infrastructure
Communication Services
HVAC and Construction
Next Generation Technologies
Textiles
Smart Textiles
{ "homeurl": "https://www.marketresearchandstatistics.com/", "resultstype": "vertical", "resultsposition": "hover", "itemscount": 4, "imagewidth": 70, "imageheight": 70, "resultitemheight": "auto", "showauthor": 0, "showdate": 0, "showdescription": 1, "charcount": 3, "noresultstext": "No results!", "didyoumeantext": "Did you mean:", "defaultImage": "https://www.marketresearchandstatistics.com/wp-content/plugins/ajax-search-pro/img/default.jpg", "highlight": 0, "highlightwholewords": 1, "openToBlank": 0, "scrollToResults": 0, "resultareaclickable": 1, "autocomplete": { "enabled": 1, "googleOnly": 0, "lang": "en" }, "triggerontype": 1, "triggeronclick": 1, "triggeronreturn": 1, "triggerOnFacetChange": 0, "overridewpdefault": 0, "redirectonclick": 1, "redirectClickTo": "results_page", "redirect_on_enter": 1, "redirectEnterTo": "results_page", "redirect_url": "?s={phrase}", "more_redirect_url": "?s={phrase}", "settingsimagepos": "left", "settingsVisible": 0, "hresulthidedesc": "0", "prescontainerheight": "400px", "pshowsubtitle": "0", "pshowdesc": "1", "closeOnDocClick": 1, "iifNoImage": "description", "iiRows": 2, "iiGutter": 5, "iitemsWidth": 200, "iitemsHeight": 200, "iishowOverlay": 1, "iiblurOverlay": 1, "iihideContent": 1, "loaderLocation": "auto", "analytics": 0, "analyticsString": "", "aapl": { "on_click": 0, "on_magnifier": 0, "on_enter": 0, "on_typing": 0 }, "compact": { "enabled": 0, "width": "100%", "closeOnMagnifier": 1, "closeOnDocument": 0, "position": "static", "overlay": 0 }, "animations": { "pc": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "fadeInDown" }, "mob": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "voidanim" } }, "autop": { "state": "disabled", "phrase": "", "count": 10 } }

Generon (Shanghai) Corporation Ltd. – Product Pipeline Review – 2015

$1,500

Global Markets Direct’s, ‘Generon (Shanghai) Corporation Ltd. – Product Pipeline Review – 2015’, provides an overview of the Generon (Shanghai) Corporation Ltd.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Generon (Shanghai) Corporation Ltd.’s,….

Total Pages: 26

generon-shanghai-corporation-ltd-product-pipeline-review-2015
600
#9e2f22

Global Markets Direct’s, ‘Generon (Shanghai) Corporation Ltd. - Product Pipeline Review - 2015’, provides an overview of the Generon (Shanghai) Corporation Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Generon (Shanghai) Corporation Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Generon (Shanghai) Corporation Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Generon (Shanghai) Corporation Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Generon (Shanghai) Corporation Ltd.’s pipeline products

Reasons to buy

- Evaluate Generon (Shanghai) Corporation Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Generon (Shanghai) Corporation Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Generon (Shanghai) Corporation Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Generon (Shanghai) Corporation Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Generon (Shanghai) Corporation Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Generon (Shanghai) Corporation Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Generon (Shanghai) Corporation Ltd. Snapshot 5
Generon (Shanghai) Corporation Ltd. Overview 5
Key Information 5
Key Facts 5
Generon (Shanghai) Corporation Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Generon (Shanghai) Corporation Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Generon (Shanghai) Corporation Ltd. - Pipeline Products Glance 10
Generon (Shanghai) Corporation Ltd. - Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Phase I Products/Combination Treatment Modalities 11
Generon (Shanghai) Corporation Ltd. - Early Stage Pipeline Products 12
IND/CTA Filed Products/Combination Treatment Modalities 12
Preclinical Products/Combination Treatment Modalities 13
Generon (Shanghai) Corporation Ltd. - Drug Profiles 14
F-627 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
F-652 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
F-637 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Generon (Shanghai) Corporation Ltd. - Pipeline Analysis 17
Generon (Shanghai) Corporation Ltd. - Pipeline Products by Target 17
Generon (Shanghai) Corporation Ltd. - Pipeline Products by Route of Administration 18
Generon (Shanghai) Corporation Ltd. - Pipeline Products by Molecule Type 19
Generon (Shanghai) Corporation Ltd. - Pipeline Products by Mechanism of Action 20
Generon (Shanghai) Corporation Ltd. - Recent Pipeline Updates 21
Generon (Shanghai) Corporation Ltd. - Dormant Projects 23
Generon (Shanghai) Corporation Ltd. - Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 25
Disclaimer 26

List of Tables
Generon (Shanghai) Corporation Ltd., Key Information 5
Generon (Shanghai) Corporation Ltd., Key Facts 5
Generon (Shanghai) Corporation Ltd. - Pipeline by Indication, 2015 7
Generon (Shanghai) Corporation Ltd. - Pipeline by Stage of Development, 2015 8
Generon (Shanghai) Corporation Ltd. - Monotherapy Products in Pipeline, 2015 9
Generon (Shanghai) Corporation Ltd. - Phase II, 2015 10
Generon (Shanghai) Corporation Ltd. - Phase I, 2015 11
Generon (Shanghai) Corporation Ltd. - IND/CTA Filed, 2015 12
Generon (Shanghai) Corporation Ltd. - Preclinical, 2015 13
Generon (Shanghai) Corporation Ltd. - Pipeline by Target, 2015 17
Generon (Shanghai) Corporation Ltd. - Pipeline by Route of Administration, 2015 18
Generon (Shanghai) Corporation Ltd. - Pipeline by Molecule Type, 2015 19
Generon (Shanghai) Corporation Ltd. - Pipeline Products by Mechanism of Action, 2015 20
Generon (Shanghai) Corporation Ltd. - Recent Pipeline Updates, 2015 21
Generon (Shanghai) Corporation Ltd. - Dormant Developmental Projects,2015 23

List of Figures
Generon (Shanghai) Corporation Ltd. - Pipeline by Top 10 Indication, 2015 7
Generon (Shanghai) Corporation Ltd. - Pipeline by Stage of Development, 2015 8
Generon (Shanghai) Corporation Ltd. - Monotherapy Products in Pipeline, 2015 9
Generon (Shanghai) Corporation Ltd. - Pipeline by Top 10 Target, 2015 17
Generon (Shanghai) Corporation Ltd. - Pipeline by Top 10 Route of Administration, 2015 18
Generon (Shanghai) Corporation Ltd. - Pipeline by Top 10 Molecule Type, 2015 19
Generon (Shanghai) Corporation Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015 20


LICENSE TYPE